KRISTIN HEYDT: Open Payments
NPI 1629242953 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 26 payments from 9 companies in 2025. Trend: 2023 $777 · 2024 $1,163 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 6 | $208 |
| Merck Sharp & Dohme LLC | 5 | $103 |
| Genmab U.S., Inc. | 3 | $64 |
| ABBVIE INC. | 3 | $61 |
| Astellas Pharma US Inc | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Caris MPI, Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $28 |
Products named: Lenvima, KEYTRUDA, Tivdak, ELAHERE, Veozah, LYNPARZA, MI CANCER SEEK, DATROWAY.
Industry payments across MO — which companies pay providers there.
